CEOS CeCors Inc (PK)

0.00 (0.0%)
Sep 29 2023 - Closed
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 0.00
Bid Price 0.0112
Ask Price 0.0146
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
CeCors Inc (PK) CEOS OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.0135 06:50:54
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0.00 - 0.0101 - 0.0977
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.0135 USD

CeCors Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.48M 332.08M 148.29M 19k -498k 0.00 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

CeCors (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No CEOS Message Board. Create One! See More Posts on CEOS Message Board See More Message Board Posts

Historical CEOS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.01420.0160.01210.0141756237,036-0.0007-4.93%
1 Month0.01680.01850.01210.0158229308,213-0.0033-19.64%
3 Months0.0380.04370.01210.0264684548,032-0.0245-64.47%
6 Months0.0360.05150.01210.0322739650,722-0.0225-62.5%
1 Year0.03740.09770.01010.04433311,218,975-0.0239-63.9%
3 Years0.0040.4850.00230.0515985798,9730.0095237.5%
5 Years0.0710.4850.00050.0454317669,403-0.0575-80.99%

CeCors (PK) Description

PsyKey Inc. is vertically integrated in the research & development, production, and commercialization of therapeutic and medicinal entheogenic, adaptogenic, nootropic ingredients and formulations for its premium functional product lines which are developed by its mycology and botany experts. PsyKey understands the importance of access to support services and healthcare professionals and is continuously engaged in the development of tools that will aid in removing barriers and providing inclusivity. PsyKey is also engaged in the scientific development of patentable technologies pertaining to the composition, bioavailability and targeted delivery of entheogen-based therapeutics. Recently the Company acquired Vetcomm. VetComm is a veteran's education, and benefits company focused on assisting the over 20 million United States veterans that qualify for underutilized annual benefits and owed compensation. As a result, billions of dollars in veteran benefits go unclaimed every month in the United States.